1. Company has clearly stated big pharma (Pfizer) is looking at the cardiovascular indication 2. mechanism of inhibiting calcium overload in the human body is already proven as a protection in brain injury by NA-1 3. Drug is 2 weeks away in being at the same stage as its 100 million dollar peers. Stock currently 40 million market cap 4. From the webinar it was stated by management that they loaded up recently because of how big this is 5. Only drug in the world with no competition to protect the heart during a heart attack in a 10 billion dollar unmet market
From the above it’s clear there will be a huge licensing agreement with a huge up front payment coming up.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)